Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SIGA TECHNOLOGIES INC Board/Management Information 2009

Dec 18, 2009

32600_rns_2009-12-18_d5704d98-5e91-464b-a385-9e9748865cc8.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 kl12024.htm CURRENT REPORT kl12024.htm Licensed to: Kramer Levin Document Created using EDGARizer 5.1.3.0 Copyright 1995 - 2009 Thomson Reuters. All rights reserved.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 15, 2009

SIGA TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware 0-23047 13-3864870
(State
or other jurisdiction of incorporation
or organization) (Commission
file number) (I.R.S.
employer identification
no.)

35 East 62nd Street New York, New York (Address of principal executive offices) 10065 (Zip code)

Registrant’s telephone number, including area code: (212) 672-9100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

r Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

r Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

r Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

r Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 15, 2009, Dr. Adnan M. Mjalli resigned from the Board of Directors of SIGA Technologies, Inc. (the “Company”), effective as of such date. Dr. Mjalli did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

By: /s/ Ayelet
Dugary
Ayelet
Dugary
Chief Financial
Officer
Date: December
18, 2009